about
Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cellsIn Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers.Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression.Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.Skin equivalents: a tool for the discovery and validation of pharmacodynamic biomarkers.Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.Expression and function of neurotrophins and their receptors in cultured human keratinocytes.A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin.Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide.Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype.Placenta growth factor is induced in human keratinocytes during wound healingExpression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivityMelanoma and Vitiligo: In Good CompanyMultiple Sclerosis Treatment and Melanoma DevelopmentInterleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses
P50
Q33195467-4E5ABCB4-304B-45B5-913B-9FF59FFDA987Q34023370-E45ECE60-958F-45D2-9FCB-30CE4EA69A81Q38841399-3E31D29C-3214-4BCB-802F-FCA518F0F448Q38930857-E5775C60-78B9-43DD-AA5B-68B8C15A2126Q39613028-AE85181F-7159-456D-A79D-E65365A1B542Q40332254-143A2431-8D4F-463F-9F78-E8B9C6D4946BQ41089394-8C9FB6DA-46F4-4131-882D-B4C58AAD8B29Q41091448-985CA00F-CB7B-4068-8586-EC609E3E9D98Q42826642-92E431EF-9FB1-4590-949C-2EF06BADCF6BQ44514708-704BB9B0-26FF-48D5-811D-A303958F813CQ44693151-B636F964-5ECB-45B8-A6C0-CBA9DEB04866Q46815664-16906D44-1591-4144-9D06-8CE925F2C54FQ47593215-95F5B577-974D-44A4-86E9-CD480966FE5AQ52558418-D6074321-39C2-4E4C-9E09-4475438D7F43Q54237522-37199162-4175-47C0-80AA-5547D83CF35FQ74199223-9EE8E372-6E09-440C-B272-89778C77C7E7Q84580388-222E6EB0-8D8F-405C-9C08-0C37C05584A0Q91299237-F4DD70AA-787B-40B2-BC2D-93CB79395D65Q93211262-B8CDD4EC-40CF-4908-825F-BD992A2952EDQ94468292-8C287CC6-03DC-4856-98DD-7A00F48C228F
P50
description
researcher ORCID ID = 0000-0001-5991-8914
@en
wetenschapper
@nl
name
Cristina M Failla
@ast
Cristina M Failla
@en
Cristina M Failla
@es
Cristina M Failla
@nl
type
label
Cristina M Failla
@ast
Cristina M Failla
@en
Cristina M Failla
@es
Cristina M Failla
@nl
prefLabel
Cristina M Failla
@ast
Cristina M Failla
@en
Cristina M Failla
@es
Cristina M Failla
@nl
P1153
6601996294
P21
P31
P496
0000-0001-5991-8914